Aug
20

EpiPen Gets First Generic Rival After Furor Over High Price

By
  • FDA clears Teva to sell a copycat of the life-saving device
  •  Pharmacists can substitute Teva device for $600 Mylan injector

EpiPen, a life-saving allergy treatment widely criticized for its high price tag, will get generic competition for the first time since the autoinjector was approved more than two decades ago.

The Food and Drug Administration on Thursday cleared Teva Pharmaceutical Industries Ltd.’s generic EpiPen and EpiPen Jr. for sale, several years after the Israeli drugmaker filed for approval. Mylan NV has attempted to thwart competition from Teva, claiming that differences in how the epinephrine-injecting devices work would confuse patients. While Teva’s device isn’t identical to the EpiPen, it will be fully substitutable at the pharmacy, the FDA said…

EpiPen Gets First Generic Rival After Furor Over High Price

Share
Categories : Finance

Leave a Reply

You must be logged in to post a comment.